Fidessa explores challenges and opportunities of Best Execution in Australia-continued

Third white paper in series on Australia looks at how firms can turn regulatory burden into competitive edge
February 7, 2012 – Fidessa group plc, provider of high-performance trading, investment management and information solutions for the world’s financial community, has today announced the publication of the third in its series of white papers looking at issues raised by the new market integrity legislation in Australia.
Entitled Beauty and the Best - the perils and opportunities of Best Execution in a multi-market structure, the paper examines different ways in which equity brokers might approach the new obligation for Best Execution, and how their buy-side clients will be affected.

This latest paper considers how far it is possible to achieve and demonstrate Best Execution in the changed equity trading landscape, exploring what it means for market participants of all types and how its implementation might play out. As with preceding papers, Beauty and Best draws on Fidessa’s global experience to highlight the critical differences between Australia’s own Best Execution requirements and those that apply in other jurisdictions. The paper goes on to assess how these may become a key point of competitive differentiation in Australia just as they have in some other markets.

read more

Source: Fidessa


Asia ETP News
HK proposed listing changes fuel fierce debate
November 20, 2016--Reform plans would shift city's balance of power between investors and issuers.
read more
BetaShares-Are Financials now good value?
November 9, 2016--As has been evident at investor briefings in recent days, Australian banks appear to be conceding that their past relatively high (by global standards) returns on equity can’t be sustained, due to pressure on net interest margins and increased capital requirements.
read more
BetaShares Australian ETF Review-October 2016
November 8, 2016--The Australian exchange traded fund industry bucked the trend of broader market declines during October and finished the month valued at a stable $24.1B, which was approximately the same value as September.
read more